Concepedia

Kevin L. Tays

KL

5

Publications

254

Citations

5

H-Index

2001

Active since

Affiliations

Johnson & Johnson (United States)(Current)

Guilford College

Kevin L. Tays is an author at Johnson & Johnson (United States) specializing in drug discovery, medicinal chemistry, and medicine.

Top concepts

Publications per year

2001–2014

5

Publications

5

Design and Pharmacological Activity of Phosphinic Acid Based NAALADase Inhibitors

Paul Jackson, Kevin L. Tays, Keith M. Maclin et al. · Journal of Medicinal Chemistry · 2001 · 91 citations · Full text

, , +20

Identification of a Potent, Selective, and Orally Active Leukotriene A<sub>4</sub> Hydrolase Inhibitor with Anti-Inflammatory Activity

Cheryl A. Grice, Kevin L. Tays, Brad M. Savall et al. · Journal of Medicinal Chemistry · 2008 · 60 citations · Full text

, , +17

Synthesis of substituted 5[H]phenanthridin-6-ones as potent poly(ADP-ribose)polymerase-1 (PARP1) inhibitors

Jia-He Li, L.S. Serdyuk, Dana Ferraris et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 54 citations · Full text

, , +3

Discovery and SAR of 6-Alkyl-2,4-diaminopyrimidines as Histamine H<sub>4</sub> Receptor Antagonists

Brad M. Savall, Frank Chavez, Kevin L. Tays et al. · Journal of Medicinal Chemistry · 2014 · 37 citations · Full text

, , +13

The SAR of 4-substituted (6,6-bicyclic) piperidine cathepsin S inhibitors

Cheryl A. Grice, Kevin L. Tays, Haripada Khatuya et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 12 citations · Full text

, , +5

Rows per page

1–5 of 5